Healthcare Realty Trust (NYSE:HR) Announces Earnings Results

Healthcare Realty Trust (NYSE:HR) posted its quarterly earnings data on Wednesday. The real estate investment trust reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.39 by $0.01, Zacks reports. The company had revenue of $309.77 million for the quarter, compared to analyst estimates of $303.81 million. Healthcare Realty Trust had a negative net margin of 45.63% and a negative return on equity of 9.42%. Healthcare Realty Trust’s quarterly revenue was down 6.3% on a year-over-year basis. During the same period in the previous year, the business posted $0.39 earnings per share. Healthcare Realty Trust updated its FY 2025 guidance to 1.560-1.600 EPS and its FY25 guidance to $1.56 to $1.60 EPS.

Healthcare Realty Trust Price Performance

NYSE:HR opened at $16.71 on Thursday. The firm has a 50 day simple moving average of $16.68 and a 200-day simple moving average of $17.42. The firm has a market cap of $5.92 billion, a PE ratio of -10.56 and a beta of 0.94. Healthcare Realty Trust has a 1-year low of $12.77 and a 1-year high of $18.90.

Insider Activity

In other Healthcare Realty Trust news, Director Thomas N. Bohjalian acquired 7,750 shares of the company’s stock in a transaction dated Friday, November 22nd. The stock was bought at an average price of $17.39 per share, with a total value of $134,772.50. Following the completion of the transaction, the director now directly owns 50,002 shares of the company’s stock, valued at approximately $869,534.78. The trade was a 18.34 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Peter F. Sr Lyle, Sr. bought 10,000 shares of the firm’s stock in a transaction dated Friday, December 13th. The stock was purchased at an average price of $17.21 per share, with a total value of $172,100.00. Following the completion of the purchase, the director now directly owns 26,576 shares of the company’s stock, valued at approximately $457,372.96. This trade represents a 60.33 % increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 18,750 shares of company stock valued at $323,723 over the last 90 days. Insiders own 0.56% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have commented on the stock. JPMorgan Chase & Co. lowered shares of Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 price objective on the stock. in a research note on Friday, December 20th. Wedbush lowered shares of Healthcare Realty Trust from a “neutral” rating to an “underperform” rating and dropped their price target for the stock from $18.00 to $16.00 in a research note on Thursday, January 2nd. Finally, Jefferies Financial Group lowered shares of Healthcare Realty Trust from a “buy” rating to a “hold” rating and dropped their price target for the stock from $19.00 to $17.00 in a research note on Thursday, January 2nd. Two equities research analysts have rated the stock with a sell rating and four have given a hold rating to the company. According to data from MarketBeat, Healthcare Realty Trust presently has an average rating of “Hold” and a consensus price target of $17.00.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.